• 1783 Citations
  • 23 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Endometrial Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pelvic Exenteration Medicine & Life Sciences
Robotics Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

Clinical cancer advances 2019: Annual report on progress against cancer from the American society of clinical oncology

Pal, S. K., Miller, M. J., Agarwal, N., Marina Chang, S., Chavez Mac Gregor, M., Cohen, E., Cole, S., Dale, W., Diefenbach, C. S. M., Disis, M. L., Dreicer, R., Graham, D. L., Henry, N. L., Jones, J., Keedy, V., Klepin, H. D., Markham, M. J., Mittendorf, E. A., Rodriguez-Galindo, C., Sabel, M. S. & 5 othersSchilsky, R. L., Sznol, M., Tap, W. D., Westin, S. N. & Johnson, B. E., Jan 1 2019, In : Journal of Clinical Oncology. 37, 10, p. 834-849 16 p.

Research output: Contribution to journalReview article

Annual Reports
Medical Oncology
Neoplasms

Microsatellite instability in endometrial cancer: New purpose for an old test

Kurnit, K. C., Westin, S. N. & Coleman, R., Jan 1 2019, In : Cancer.

Research output: Contribution to journalComment/debate

Hereditary Nonpolyposis Colorectal Neoplasms
Microsatellite Instability
Endometrial Neoplasms
Immunotherapy
Turcot syndrome
2 Citations (Scopus)

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

Konstantinopoulos, P. A., Barry, W. T., Birrer, M., Westin, S. N., Cadoo, K. A., Shapiro, G. I., Mayer, E. L., O'Cearbhaill, R. E., Coleman, R., Kochupurakkal, B., Whalen, C., Curtis, J., Farooq, S., Luo, W., Eismann, J., Buss, M. K., Aghajanian, C., Mills, G. B., Palakurthi, S., Kirschmeier, P. & 8 othersLiu, J., Cantley, L. C., Kaufmann, S. H., Swisher, E. M., D'Andrea, A. D., Winer, E., Wulf, G. M. & Matulonis, U. A., Apr 1 2019, In : The lancet oncology. 20, 4, p. 570-580 11 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Breast Neoplasms
Histology
Ovarian Neoplasms
Recombinational DNA Repair
1 Citation (Scopus)

Prognostic factors impacting survival in early stage uterine carcinosarcoma

Kurnit, K. C., Previs, R. A., Soliman, P. T., Westin, S. N., Klopp, A. H., Fellman, B. M., Lu, K. H., Ramondetta, L. M. & Fleming, N., Jan 1 2019, In : Gynecologic oncology. 152, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

Carcinosarcoma
Survival
Rhabdomyosarcoma
Brachytherapy
Combination Drug Therapy
10 Citations (Scopus)

A phase i open-label study to identify a dosing regimen of the pan-akt inhibitor azd5363 for evaluation in solid tumors and in pik3ca-mutated breast and gynecologic cancers

Banerji, U., Dean, E. J., Alejandro Perez-Fidalgo, J., Batist, G., Bedard, P. L., You, B., Westin, S. N., Kabos, P., Garrett, M. D., Tall, M., Ambrose, H., Carl Barrett, J., Hedley Carr, T., Amy Cheung, S. Y., Corcoran, C., Cullberg, M., Davies, B. R., de Bruin, E. C., Elvin, P., Foxley, A. & 9 othersLawrence, P., Lindemann, J. P. O., Maudsley, R., Pass, M., Rowlands, V., Rugman, P., Schiavon, G., Yates, J. & Schellens, J. H. M., May 1 2018, In : Clinical Cancer Research. 24, 9, p. 2050-2059 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Appointments and Schedules
Neoplasms
Hyperglycemia
Diarrhea